5-Hydroxytryptophan (5-HTP) is the immediate precursor in the biosynthesis of the neurotransmitter 5-hydroxytryptamine (5 HT or serotonin). 5-HT is synthesized from the amino acid L-tryptophan.

- Nutritionally supplies the immediate metabolic precursor to Serotonin
- Dietary supplementation may enhance levels of:
   1. Serotonin
   2. Melatonin
   3. Catecholamines
   4. Endorphins
- May positively enhance mood
- May enhance the sleep cycle
- May reduce discomfort in patients with chronic pain
- May regulate feeding patterns and have positive bariatric (weight management) effects

Ingredients per vcapsule:
5-Hydroxy L-Tryptophan 50 mg

Suggested use:
As a dietary supplement, take 1-2 capsules twice daily between
meals or as directed by your health care practitioner.

Contraindications:
1.  Patients on MAOIs (approved 2 weeks after discontinuation)
2.  Patients with carcinoid tumors
3.  Should not be used concurrently with medications such as: SSRIs, tricyclic antidepressants, MAOIs.
4.  Should not be used concurrently with serotonin 5-HT1 receptor agonists including naratriptan, sumatriptan, and zolmitriptan.
5.  Patients with ischemic heart disease (Hx of myocardial infarction, angina pectoris, documented silent ischemia)
6.  Patients with Hx of coronary artery spasm
7.  Uncontrolled hypertension
8.  Pregnant women and nursing mothers

Keep out of the reach of children.

Side effects: Due to excessive serotonin production could include:
Nausea, diarrhea, loss of appetite, vomiting, difficult breathing, dilation
of pupils, exaggerated reflexes, loss of muscle coordination, blurring of
vision and cardiac dysrythmias.

Note: Carbidopa may increase 5-HTP transport across the blood brain
barrier due to decreased peripheral 5-HTP metabolism.

Methyldopa inhibits conversion of 5-HTP to serotonin.

5-Hydroxytryptophan (5-HTP) is the immediate precursor in the biosynthesis of the neurotransmitter 5-hydroxytryptamine (5 HT or serotonin). 5-HT is synthesized from the amino acid L-tryptophan.

5-HTP has replaced the use of L-tryptophan in the United States. In 1989 patients taking L-tryptophan developed a negative and debilitating reaction called eosinophilia-myalgia syndrome. Upon further study it was determined that the culprit was not the L-tryptophan but a bacterial contaminate in the formula.

All L-tryptophan products associated with the syndrome were found to come from genetically modified bacterial recombinant production methods. Even though L- tryptophan was proven to be safe, it never recovered from this incident. 5-HTP was created to fill the gap created by the removal of L-tryptophan from the marketplace. Small amounts of 5-HTP, as well as serotonin, are found in bananas, tomatoes, plums, avocados, eggplant, walnuts and pineapples. A common commercial source of 5-HTP is Griffonia simplicfolia, a relative to carob.

5-HTP’s possible pain reduction benefit comes from its conversion to serotonin and to the observed effect of raising beta-endorphin and platelet met-enkephalin levels. Serum leptin levels increased following 5-HTP injection in mice. This may explain 5-HTP’s beneficial effect on weight management. Additionally, 5-HTP has been shown to reduce carbohydrate intake.